{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:02:45Z","timestamp":1762452165751,"version":"build-2065373602"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100013843","name":"Ministry of Innovative Development of the Republic of Uzbekistan","doi-asserted-by":"crossref","award":["F-FA-2021-359"],"award-info":[{"award-number":["F-FA-2021-359"]}],"id":[{"id":"10.13039\/501100013843","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CAS, PIFI fund","award":["2024VBA0019"],"award-info":[{"award-number":["2024VBA0019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10822-025-00623-2","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T23:08:13Z","timestamp":1751670493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["3CLpro of SARS-CoV-2 as a new target for bufadienolides: in silico and in vitro study"],"prefix":"10.1007","volume":"39","author":[{"given":"Muzaffar","family":"Kayumov","sequence":"first","affiliation":[]},{"given":"Jamoliddin","family":"Razzokov","sequence":"additional","affiliation":[]},{"given":"Mukhriddin","family":"Makhkamov","sequence":"additional","affiliation":[]},{"given":"Murodjon","family":"Radjabov","sequence":"additional","affiliation":[]},{"given":"Nurkhodja","family":"Mukhamedov","sequence":"additional","affiliation":[]},{"given":"Makhmudjon","family":"Khakimov","sequence":"additional","affiliation":[]},{"given":"Akmal M.","family":"Asrorov","sequence":"additional","affiliation":[]},{"given":"Okhunjon","family":"Khasanov","sequence":"additional","affiliation":[]},{"given":"Ansor","family":"Yashinov","sequence":"additional","affiliation":[]},{"given":"Mugrajitdin","family":"Tashmukhamedov","sequence":"additional","affiliation":[]},{"given":"Ahmidin","family":"Wali","sequence":"additional","affiliation":[]},{"given":"Abulimiti","family":"Yili","sequence":"additional","affiliation":[]},{"given":"Sharafitdin","family":"Mirzaakhmedov","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,7,5]]},"reference":[{"key":"623_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al (2020) A novel coronavirus from patients with pneumonia in china, 2019. N Engl J Med 382:727\u2013733. https:\/\/doi.org\/10.1056\/NEJMoa2001017","journal-title":"N Engl J Med"},{"key":"623_CR2","doi-asserted-by":"publisher","unstructured":"Beyerstedt S, Casaro EB, Rangel \u00c9 (2021) B. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. European journal of clinical microbiology & infectious diseases: official publication of the European society of clinical microbiology. 40, 905\u2013919 https:\/\/doi.org\/10.1007\/s10096-020-04138-6","DOI":"10.1007\/s10096-020-04138-6"},{"key":"623_CR3","doi-asserted-by":"publisher","first-page":"173455","DOI":"10.1016\/j.ejphar.2020.173455","volume":"884","author":"S Sharifkashani","year":"2020","unstructured":"Sharifkashani S, Bafrani MA, Khaboushan AS, Pirzadeh M, Kheirandish A, Bali Y (2020) Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: potential therapeutic targeting. Eur J Pharmacol 884:173455. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173455","journal-title":"Eur J Pharmacol"},{"key":"623_CR4","doi-asserted-by":"publisher","first-page":"102907","DOI":"10.1016\/j.ebiom.2020.102907","volume":"58","author":"MK Chung","year":"2020","unstructured":"Chung MK, Karnik S, Saef J, Bergmann C, Barnard J, Lederman MM et al (2020) SARS-CoV-2 and ACE2: the biology and clinical data settling the ARB and ACEI controversy. EBioMedicine 58:102907. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102907","journal-title":"EBioMedicine"},{"key":"623_CR5","doi-asserted-by":"publisher","first-page":"117905","DOI":"10.1016\/j.lfs.2020.117905","volume":"256","author":"N Banu","year":"2020","unstructured":"Banu N, Panikar SS, Leal LR, Leal AR (2020) Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to macrophage activation syndrome: therapeutic implications. Life Sci 256:117905. https:\/\/doi.org\/10.1016\/j.lfs.2020.117905","journal-title":"Life Sci"},{"key":"623_CR6","doi-asserted-by":"crossref","unstructured":"Hulswit RJG, de Haan CAM, Bosch BJ (2016) Chapter Two - Coronavirus Spike Protein and Tropism Changes. In: Advances in Virus Research, Ziebuhr, J. Ed., Academic Press, Vol. 96, pp. 29\u201357","DOI":"10.1016\/bs.aivir.2016.08.004"},{"key":"623_CR7","doi-asserted-by":"publisher","first-page":"204993612110243","DOI":"10.1177\/20499361211024372","volume":"8","author":"A Sanyaolu","year":"2021","unstructured":"Sanyaolu A, Okorie C, Marinkovic A, Haider N, Abbasi AF, Jaferi U et al (2021) The emerging SARS-CoV-2 variants of concern. Therapeutic Adv Infect Disease 8:20499361211024372. https:\/\/doi.org\/10.1177\/20499361211024372","journal-title":"Therapeutic Adv Infect Disease"},{"key":"623_CR8","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1080\/07391102.2020.1845800","volume":"40","author":"VN Badavath","year":"2022","unstructured":"Badavath VN, Kumar A, Samanta PK, Maji S, Das A, Blum G et al (2022) Determination of potential inhibitors based on Isatin derivatives against SARS-CoV-2 main protease (m(pro)): a molecular docking, molecular dynamics and structure-activity relationship studies. J Biomol Struct Dyn 40:3110\u20133128. https:\/\/doi.org\/10.1080\/07391102.2020.1845800","journal-title":"J Biomol Struct Dyn"},{"key":"623_CR9","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1002\/jmv.26814","volume":"93","author":"V Anirudhan","year":"2021","unstructured":"Anirudhan V, Lee H, Cheng H, Cooper L, Rong L, Targeting (2021) SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19. J Med Virol 93:2722\u20132734. https:\/\/doi.org\/10.1002\/jmv.26814","journal-title":"J Med Virol"},{"key":"623_CR10","doi-asserted-by":"publisher","first-page":"22677","DOI":"10.1038\/srep22677","volume":"6","author":"F Wang","year":"2016","unstructured":"Wang F, Chen C, Tan W, Yang K, Yang H (2016) Structure of main protease from human coronavirus NL63: insights for wide spectrum Anti-Coronavirus drug design. Sci Rep 6:22677. https:\/\/doi.org\/10.1038\/srep22677","journal-title":"Sci Rep"},{"key":"623_CR11","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1002\/med.21783","volume":"41","author":"M Xiong","year":"2021","unstructured":"Xiong M, Su H, Zhao W, Xie H, Shao Q, Xu Y (2021) What coronavirus 3\u00a0C-like protease tells us: from structure, substrate selectivity, to inhibitor design. Med Res Rev 41:1965\u20131998. https:\/\/doi.org\/10.1002\/med.21783","journal-title":"Med Res Rev"},{"key":"623_CR12","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1021\/acs.jmedchem.5b01461","volume":"59","author":"T Pillaiyar","year":"2016","unstructured":"Pillaiyar T, Manickam M, Namasivayam V, Hayashi Y, Jung SH (2016) An overview of severe acute respiratory Syndrome-Coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy. J Med Chem 59:6595\u20136628. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01461","journal-title":"J Med Chem"},{"key":"623_CR13","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1126\/science.abb4489","volume":"368","author":"W Dai","year":"2020","unstructured":"Dai W, Zhang B, Jiang XM, Su H, Li J, Zhao Y et al (2020) Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Sci (New York N Y) 368:1331\u20131335. https:\/\/doi.org\/10.1126\/science.abb4489","journal-title":"Sci (New York N Y)"},{"key":"623_CR14","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1021\/acs.jnatprod.6b01018","volume":"80","author":"HY Tian","year":"2017","unstructured":"Tian HY, Ruan LJ, Yu T, Zheng QF, Chen NH, Wu RB et al (2017) Bufospirostenin A and Bufogargarizin C, steroids with rearranged skeletons from the Toad Bufo bufo gargarizans. J Nat Prod 80:1182\u20131186. https:\/\/doi.org\/10.1021\/acs.jnatprod.6b01018","journal-title":"J Nat Prod"},{"key":"623_CR15","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/ddr.22072","volume":"84","author":"AM Asrorov","year":"2023","unstructured":"Asrorov AM, Kayumov M, Mukhamedov N, Yashinov A, Mirakhmetova Z, Huang Y et al (2023) Toad venom bufadienolides and bufotoxins: an updated review. Drug Dev Res 84:815\u2013838. https:\/\/doi.org\/10.1002\/ddr.22072","journal-title":"Drug Dev Res"},{"key":"623_CR16","doi-asserted-by":"publisher","unstructured":"El-Seedi HR, Yosri N, El-Aarag B, Mahmoud SH, Zayed A, Du M et al (2022) Chemistry and the potential antiviral, anticancer, and Anti-Inflammatory activities of cardiotonic steroids derived from toads. Molecules 27. https:\/\/doi.org\/10.3390\/molecules27196586","DOI":"10.3390\/molecules27196586"},{"key":"623_CR17","doi-asserted-by":"publisher","first-page":"1044027","DOI":"10.3389\/fphar.2022.1044027","volume":"13","author":"D Zou","year":"2022","unstructured":"Zou D, Wang Q, Chen T, Sang D, Yang T, Wang Y et al (2022) Bufadienolides originated from Toad source and their anti-inflammatory activity. Front Pharmacol 13:1044027. https:\/\/doi.org\/10.3389\/fphar.2022.1044027","journal-title":"Front Pharmacol"},{"key":"623_CR18","doi-asserted-by":"publisher","unstructured":"Jin YH, Jeon S, Lee J, Kim S, Jang MS, Park CM et al (2021) Broad spectrum antiviral properties of cardiotonic steroids used as potential therapeutics for emerging coronavirus infections. Pharmaceutics 13. https:\/\/doi.org\/10.3390\/pharmaceutics13111839","DOI":"10.3390\/pharmaceutics13111839"},{"key":"623_CR19","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s11094-008-0024-y","volume":"41","author":"AB Soliev","year":"2007","unstructured":"Soliev AB, Mirzaakhmedov SY, Tashmukhamedov MS, Kamaev FG, Salikhov SI, Zakirova NI et al (2007) Chemical composition and biological activity of total bufadienolides from the Central-Asian Bufo viridis Toad venom. Pharm Chem J 41:600\u2013604. https:\/\/doi.org\/10.1007\/s11094-008-0024-y","journal-title":"Pharm Chem J"},{"key":"623_CR20","doi-asserted-by":"publisher","unstructured":"Kayumov M, Mukhamedov N, Ashurov J, Eshimbetov A, Asrorov AM, Yashinov A et al (2025) A new polymorphic form of 3b,11a,14-trihydroxy-5b,14b-bufa-20,22-dienolide (telocinobufagin) and its p300 and NNMT inhibitory activity. J Mol Struct 141503. https:\/\/doi.org\/10.1016\/j.molstruc.2025.141503","DOI":"10.1016\/j.molstruc.2025.141503"},{"key":"623_CR21","doi-asserted-by":"publisher","unstructured":"Liu Y, Yang X, Gan J, Chen S, Xiao Z-X, Cao Y (2022) CB-Dock2: improved protein\u2013ligand blind Docking by integrating cavity detection, Docking and homologous template fitting. Nucleic Acids Res 50(W159\u2013W64). https:\/\/doi.org\/10.1093\/nar\/gkac394. %J Nucleic Acids Research","DOI":"10.1093\/nar\/gkac394"},{"key":"623_CR22","doi-asserted-by":"publisher","unstructured":"Yang X, Liu Y, Gan J, Xiao Z-X, Cao Y (2022) FitDock: protein\u2013ligand Docking by template fitting. Brief Bioinform 23. https:\/\/doi.org\/10.1093\/bib\/bbac087","DOI":"10.1093\/bib\/bbac087"},{"key":"623_CR23","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1080\/10406638.2022.2036778","volume":"43","author":"J Devasia","year":"2023","unstructured":"Devasia J, Sampath C, Kavita K, Sonam S, Francis J, Mithun R et al (2023) Synthesis, DFT and in Silico Anti-COVID evaluation of novel tetrazole analogues. Polycycl Aromat Compd 43:1941\u20131956. https:\/\/doi.org\/10.1080\/10406638.2022.2036778","journal-title":"Polycycl Aromat Compd"},{"key":"623_CR24","doi-asserted-by":"publisher","first-page":"17365","DOI":"10.1074\/jbc.AC120.016154","volume":"295","author":"DW Kneller","year":"2020","unstructured":"Kneller DW, Phillips G, Weiss KL, Pant S, Zhang Q, O\u2019Neill HM et al (2020) Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography. J Biol Chem 295:17365\u201317373. https:\/\/doi.org\/10.1074\/jbc.AC120.016154","journal-title":"J Biol Chem"},{"key":"623_CR25","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1021\/acs.jcim.9b00739","volume":"59","author":"HS Fernandes","year":"2019","unstructured":"Fernandes HS, Sousa SF, Cerqueira NVMD, Store-A (2019) VMD plugin to browse, discover, and install VMD extensions. J Chem Inf Model 59:4519\u20134523. https:\/\/doi.org\/10.1021\/acs.jcim.9b00739","journal-title":"J Chem Inf Model"},{"key":"623_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/1097-0282(2000)56:4<257::aid-bip10029>3.0.co;2-w","volume":"56","author":"AD MacKerell Jr","year":"2000","unstructured":"MacKerell AD Jr., Banavali N, Foloppe N (2000) Development and current status of the CHARMM force field for nucleic acids. Biopolymers 56:257\u2013265. https:\/\/doi.org\/10.1002\/1097-0282(2000)56:4%3C;257:aid-bip10029%3E;3.0.co;2-w","journal-title":"Biopolymers"},{"key":"623_CR27","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/jcc.21816","volume":"32","author":"V Zoete","year":"2011","unstructured":"Zoete V, Cuendet MA, Grosdidier A, Michielin O (2011) SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem 32:2359\u20132368. https:\/\/doi.org\/10.1002\/jcc.21816","journal-title":"J Comput Chem"},{"key":"623_CR28","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark P, Nilsson L (2001) Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J Phys Chem A 105:9954\u20139960. https:\/\/doi.org\/10.1021\/jp003020w","journal-title":"J Phys Chem A"},{"key":"623_CR29","doi-asserted-by":"publisher","first-page":"014101","DOI":"10.1063\/1.2408420","volume":"126","author":"G Bussi","year":"2007","unstructured":"Bussi G, Donadio D, Parrinello M (2007) Canonical sampling through velocity rescaling. J Chem Phys 126:014101. https:\/\/doi.org\/10.1063\/1.2408420","journal-title":"J Chem Phys"},{"key":"623_CR30","doi-asserted-by":"crossref","unstructured":"Parrinello M, Rahman AJ (1981) J.o.A.p. Polymorphic transitions in single crystals: A new molecular dynamics method. 52, 7182\u20137190","DOI":"10.1063\/1.328693"},{"key":"623_CR31","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/jcc.540130812","volume":"13","author":"S Kumar","year":"1992","unstructured":"Kumar S, Rosenberg JM, Bouzida D, Swendsen RH, Kollman PA (1992) The weighted histogram analysis method for free-energy calculations on biomolecules. I. The method. J Comput Chem 13:1011\u20131021","journal-title":"J Comput Chem"},{"key":"623_CR32","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1529\/biophysj.106.081406","volume":"91","author":"JS Hub","year":"2006","unstructured":"Hub JS, de Groot BL (2006) Does CO2 permeate through aquaporin-1? Biophys J 91:842\u2013848. https:\/\/doi.org\/10.1529\/biophysj.106.081406","journal-title":"Biophys J"},{"key":"623_CR33","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"623_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3\u201326. https:\/\/doi.org\/10.1016\/s0169-409x(00)00129-0","journal-title":"Adv Drug Deliv Rev"},{"key":"623_CR35","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1021\/ci034243x","volume":"44","author":"JS Delaney","year":"2004","unstructured":"Delaney JS (2004) ESOL: estimating aqueous solubility directly from molecular structure. J Chem Inf Comput Sci 44:1000\u20131005. https:\/\/doi.org\/10.1021\/ci034243x","journal-title":"J Chem Inf Comput Sci"},{"key":"623_CR36","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1021\/ci200387c","volume":"52","author":"J Ali","year":"2012","unstructured":"Ali J, Camilleri P, Brown MB, Hutt AJ, Kirton SB (2012) Revisiting the general solubility equation: in Silico prediction of aqueous solubility incorporating the effect of topographical Polar surface area. J Chem Inf Model 52:420\u2013428. https:\/\/doi.org\/10.1021\/ci200387c","journal-title":"J Chem Inf Model"},{"key":"623_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","volume":"10","author":"M Tahir Ul Qamar","year":"2020","unstructured":"Tahir Ul Qamar M, Alqahtani SM, Alamri MA, Chen LL (2020) Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal 10:313\u2013319. https:\/\/doi.org\/10.1016\/j.jpha.2020.03.009","journal-title":"J Pharm Anal"},{"key":"623_CR38","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1080\/07391102.2020.1777901","volume":"39","author":"NA Murugan","year":"2021","unstructured":"Murugan NA, Pandian CJ, Jeyakanthan J (2021) Computational investigation on Andrographis paniculata phytochemicals to evaluate their potency against SARS-CoV-2 in comparison to known antiviral compounds in drug trials. J Biomol Struct Dyn 39:4415\u20134426. https:\/\/doi.org\/10.1080\/07391102.2020.1777901","journal-title":"J Biomol Struct Dyn"},{"key":"623_CR39","doi-asserted-by":"publisher","first-page":"106055","DOI":"10.1016\/j.ijantimicag.2020.106055","volume":"56","author":"J He","year":"2020","unstructured":"He J, Hu L, Huang X, Wang C, Zhang Z, Wang Y et al (2020) Potential of coronavirus 3\u00a0C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: insights from structures of protease and inhibitors. Int J Antimicrob Agents 56:106055. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106055","journal-title":"Int J Antimicrob Agents"},{"key":"623_CR40","doi-asserted-by":"publisher","unstructured":"Liu M, Li J, Liu W, Yang Y, Zhang M, Ye Y et al (2023) The S1\u2019-S3\u2019 Pocket of the SARS-CoV-2 Main Protease Is Critical for Substrate Selectivity and Can Be Targeted with Covalent Inhibitors. Angew Chem Int Ed Engl 62(e202309657). https:\/\/doi.org\/10.1002\/anie.202309657","DOI":"10.1002\/anie.202309657"},{"key":"623_CR41","doi-asserted-by":"publisher","unstructured":"Schreiner W, Karch R, Knapp B, Ilieva N (2012) Relaxation estimation of RMSD in molecular dynamics immunosimulations. Computational and mathematical methods in medicine. 2012, 173521 https:\/\/doi.org\/10.1155\/2012\/173521","DOI":"10.1155\/2012\/173521"},{"key":"623_CR42","doi-asserted-by":"publisher","unstructured":"Saquib Q, Bakheit AH, Ahmed S, Ansari SM, Al-Salem AM, Al-Khedhairy AA (2024) Identification of phytochemicals from Arabian Peninsula medicinal plants as strong binders to SARS-CoV-2 proteases (3CL(Pro) and PL(Pro)) by molecular Docking and dynamic simulation studies. Molecules 29. https:\/\/doi.org\/10.3390\/molecules29050998","DOI":"10.3390\/molecules29050998"},{"key":"623_CR43","doi-asserted-by":"publisher","first-page":"1518463","DOI":"10.3389\/fphar.2025.1518463","volume":"16","author":"M Kayumov","year":"2025","unstructured":"Kayumov M, Marimuthu P, Razzokov J, Mukhamedov N, Asrorov A, Berdiev NS et al (2025) Computational and in vitro evaluation of sumac-derived (\u00a9)rutan compounds towards Sars-CoV-2\u00a0M(pro) Inhibition. Front Pharmacol 16:1518463. https:\/\/doi.org\/10.3389\/fphar.2025.1518463","journal-title":"Front Pharmacol"},{"key":"623_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10822-016-0005-2","volume":"31","author":"K Liu","year":"2017","unstructured":"Liu K, Watanabe E, Kokubo H (2017) Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations. J Comput Aided Mol Des 31:201\u2013211. https:\/\/doi.org\/10.1007\/s10822-016-0005-2","journal-title":"J Comput Aided Mol Des"},{"key":"623_CR45","doi-asserted-by":"publisher","first-page":"8722","DOI":"10.1021\/jp302103t","volume":"116","author":"NC Benson","year":"2012","unstructured":"Benson NC, Daggett V (2012) A comparison of multiscale methods for the analysis of molecular dynamics simulations. J Phys Chem 116:8722\u20138731. https:\/\/doi.org\/10.1021\/jp302103t","journal-title":"J Phys Chem"},{"key":"623_CR46","doi-asserted-by":"publisher","first-page":"1060076","DOI":"10.3389\/fmolb.2023.1060076","volume":"10","author":"A Samad","year":"2023","unstructured":"Samad A, Ajmal A, Mahmood A, Khurshid B, Li P, Jan SM et al (2023) Identification of novel inhibitors for SARS-CoV-2 as therapeutic options using machine learning-based virtual screening, molecular Docking and MD simulation. Front Mol Biosci 10:1060076. https:\/\/doi.org\/10.3389\/fmolb.2023.1060076","journal-title":"Front Mol Biosci"},{"key":"623_CR47","doi-asserted-by":"publisher","first-page":"114320","DOI":"10.1016\/j.biopha.2023.114320","volume":"160","author":"S Kari","year":"2023","unstructured":"Kari S, Murugesan A, Thiyagarajan R, Kidambi S, Razzokov J, Selvaraj C et al (2023) Bias-force guided simulations combined with experimental validations towards GPR17 modulators identification. Biomed pharmacotherapy = Biomedecine Pharmacotherapie 160:114320. https:\/\/doi.org\/10.1016\/j.biopha.2023.114320","journal-title":"Biomed pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"623_CR48","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","volume":"30","author":"C Ma","year":"2020","unstructured":"Ma C, Sacco MD, Hurst B, Townsend JA, Hu Y, Szeto T, Boceprevir et al (2020) GC-376, and Calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease. Cell Res 30:678\u2013692. https:\/\/doi.org\/10.1038\/s41422-020-0356-z","journal-title":"Cell Res"},{"key":"623_CR49","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jep.2016.03.062","volume":"187","author":"Q Meng","year":"2016","unstructured":"Meng Q, Yau LF, Lu JG, Wu ZZ, Zhang BX, Wang JR et al (2016) Chemical profiling and cytotoxicity assay of bufadienolides in Toad venom and Toad skin. J Ethnopharmacol 187:74\u201382. https:\/\/doi.org\/10.1016\/j.jep.2016.03.062","journal-title":"J Ethnopharmacol"},{"key":"623_CR50","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1021\/jm0492002","volume":"48","author":"YCA Martin","year":"2005","unstructured":"Martin YCA, Bioavailability Score (2005) J Med Chem 48:3164\u20133170. https:\/\/doi.org\/10.1021\/jm0492002","journal-title":"J Med Chem"},{"key":"623_CR51","doi-asserted-by":"publisher","first-page":"e06001","DOI":"10.1016\/j.heliyon.2021.e06001","volume":"7","author":"DN Illian","year":"2021","unstructured":"Illian DN, Siregar ES, Sumaiyah S, Utomo AR, Nuryawan A, Basyuni M (2021) Potential compounds from several Indonesian plants to prevent SARS-CoV-2 infection: A mini-review of SARS-CoV-2 therapeutic targets. Heliyon 7:e06001. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06001","journal-title":"Heliyon"},{"key":"623_CR52","doi-asserted-by":"crossref","unstructured":"Su, H., Yao, S., Zhao, W., Li, M., Liu, J., Shang, W., et al. Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease <em>in vitro<\/em&gt. bioRxiv: the preprint server for biology. 2020, 2020.04.13.038687 https:\/\/doi.org\/10.1101\/2020.04.13.038687","DOI":"10.1101\/2020.04.13.038687"},{"key":"623_CR53","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.bbrc.2022.04.086","volume":"611","author":"J Feng","year":"2022","unstructured":"Feng J, Li D, Zhang J, Yin X, Li J (2022) Crystal structure of SARS-CoV 3\u00a0C-like protease with Baicalein. Biochem Biophys Res Commun 611:190\u2013194. https:\/\/doi.org\/10.1016\/j.bbrc.2022.04.086","journal-title":"Biochem Biophys Res Commun"},{"key":"623_CR54","doi-asserted-by":"publisher","first-page":"1425759","DOI":"10.3389\/fpls.2024.1425759","volume":"15","author":"T Ruan","year":"2024","unstructured":"Ruan T, Xiang ZR, Zhang YW, Fan SR, Ren J, Zhao Q et al (2024) Diterpenoids target SARS-CoV-2 RdRp from the roots of Euphorbia fischeriana Steud. Front Plant Sci 15:1425759. https:\/\/doi.org\/10.3389\/fpls.2024.1425759","journal-title":"Front Plant Sci"},{"key":"623_CR55","doi-asserted-by":"publisher","unstructured":"Olubiyi OO, Olagunju M, Keutmann M, Loschwitz J, Strodel B (2020) High throughput virtual screening to discover inhibitors of the main protease of the coronavirus SARS-CoV-2. Molecules 25. https:\/\/doi.org\/10.3390\/molecules25143193","DOI":"10.3390\/molecules25143193"},{"key":"623_CR56","doi-asserted-by":"publisher","first-page":"106134","DOI":"10.1016\/j.fitote.2024.106134","volume":"177","author":"J Ren","year":"2024","unstructured":"Ren J, Fan SR, Cai J, Ruan T, Chen Y, Xiang ZR et al (2024) Potential SARS-CoV-2\u00a0M(pro) steroid inhibitors from Aphanamixis polystachya (Wall.) R. N. Parker. Fitoterapia 177:106134. https:\/\/doi.org\/10.1016\/j.fitote.2024.106134","journal-title":"Fitoterapia"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00623-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00623-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00623-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:56:34Z","timestamp":1762451794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00623-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["623"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00623-2","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2025,7,5]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}